$OXGN MLV Maintains Buy On Oxigene Following Presentation Of Phase 2 Data In Recurrent Ovarian Cancer http://www.smarteranalyst.com/2014/11/10/mlv-maintains-buy-on-oxigene-following-presentation-of-phase-2-data-in-recurrent-ovarian-cancer/